# Novo Nordisk operating income entity: /record/novo-nordisk.md predicate: operating_income page: /record/novo-nordisk/operating_income as_of: 2026-11-10 cite: AsOf. "Novo Nordisk operating income: 127,658,000,000 DKK", as of 2025-12-31. Claim clm_672756B8F8A9, https://asof.is/claim/clm_672756B8F8A9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm. As of November 10, 2026, Novo Nordisk's operating income on the AsOf record is 127.66 billion DKK, dated December 31, 2025, from a primary source (sec.gov). 7 claims on Novo Nordisk's operating income, 1 open and 6 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Current operating income What the record asserts on 2026-11-10. - [Novo Nordisk](/record/novo-nordisk.md) | operating_income | 127,658,000,000 DKK | valid 2025-12-31 to present | conf 0.95 | valid | [clm_672756B8F8A9](/claim/clm_672756B8F8A9.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Novo Nordisk](/record/novo-nordisk.md) | operating_income | 52,483,000,000 DKK | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_D272A9AE2D76](/claim/clm_D272A9AE2D76.md) | [clm_B2B75C38DC99](/claim/clm_B2B75C38DC99.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/0001628280-22-001639-index.htm - [Novo Nordisk](/record/novo-nordisk.md) | operating_income | 54,126,000,000 DKK | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_4E462623C749](/claim/clm_4E462623C749.md) | [clm_D272A9AE2D76](/claim/clm_D272A9AE2D76.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/0001628280-22-001639-index.htm - [Novo Nordisk](/record/novo-nordisk.md) | operating_income | 58,644,000,000 DKK | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_F3418E0D3161](/claim/clm_F3418E0D3161.md) | [clm_4E462623C749](/claim/clm_4E462623C749.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/0001628280-22-001639-index.htm - [Novo Nordisk](/record/novo-nordisk.md) | operating_income | 74,809,000,000 DKK | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_792EA3966BEF](/claim/clm_792EA3966BEF.md) | [clm_F3418E0D3161](/claim/clm_F3418E0D3161.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000162828023001868/0001628280-23-001868-index.htm - [Novo Nordisk](/record/novo-nordisk.md) | operating_income | 102,574,000,000 DKK | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_109041F6F3C0](/claim/clm_109041F6F3C0.md) | [clm_792EA3966BEF](/claim/clm_792EA3966BEF.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000162828024002635/0001628280-24-002635-index.htm - [Novo Nordisk](/record/novo-nordisk.md) | operating_income | 128,339,000,000 DKK | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_672756B8F8A9](/claim/clm_672756B8F8A9.md) | [clm_109041F6F3C0](/claim/clm_109041F6F3C0.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm - [Novo Nordisk](/record/novo-nordisk.md) | operating_income | 127,658,000,000 DKK | valid 2025-12-31 to present | conf 0.95 | valid | [clm_672756B8F8A9](/claim/clm_672756B8F8A9.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm ## What replaced what - 52.48 billion DKK (2019-12-31 to 2020-12-31, [clm_B2B75C38DC99](/claim/clm_B2B75C38DC99.md)) was replaced by 54.13 billion DKK from 2020-12-31 ([clm_D272A9AE2D76](/claim/clm_D272A9AE2D76.md)) - 54.13 billion DKK (2020-12-31 to 2021-12-31, [clm_D272A9AE2D76](/claim/clm_D272A9AE2D76.md)) was replaced by 58.64 billion DKK from 2021-12-31 ([clm_4E462623C749](/claim/clm_4E462623C749.md)) - 58.64 billion DKK (2021-12-31 to 2022-12-31, [clm_4E462623C749](/claim/clm_4E462623C749.md)) was replaced by 74.81 billion DKK from 2022-12-31 ([clm_F3418E0D3161](/claim/clm_F3418E0D3161.md)) - 74.81 billion DKK (2022-12-31 to 2023-12-31, [clm_F3418E0D3161](/claim/clm_F3418E0D3161.md)) was replaced by 102.57 billion DKK from 2023-12-31 ([clm_792EA3966BEF](/claim/clm_792EA3966BEF.md)) - 102.57 billion DKK (2023-12-31 to 2024-12-31, [clm_792EA3966BEF](/claim/clm_792EA3966BEF.md)) was replaced by 128.34 billion DKK from 2024-12-31 ([clm_109041F6F3C0](/claim/clm_109041F6F3C0.md)) - 128.34 billion DKK (2024-12-31 to 2025-12-31, [clm_109041F6F3C0](/claim/clm_109041F6F3C0.md)) was replaced by 127.66 billion DKK from 2025-12-31 ([clm_672756B8F8A9](/claim/clm_672756B8F8A9.md)) ## Questions this record answers ### What is Novo Nordisk's current operating income? 127.66 billion DKK, dated December 31, 2025, from a primary source (sec.gov). The record asserts this claim as of November 10, 2026 (status valid, confidence 0.95). ### When did Novo Nordisk's operating income last change? The latest value on the record is 127.66 billion DKK, dated December 31, 2025; before it the record holds 128.34 billion DKK, dated December 31, 2024 and closed on December 31, 2025. ### What was Novo Nordisk's operating income before 127.66 billion DKK? 128.34 billion DKK, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/novo-nordisk/operating_income (markdown: /record/novo-nordisk/operating_income.md) - Entity twin: /record/novo-nordisk.md ยท timeline: /timelines/novo-nordisk.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.